| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Neuroscience | 39 | 329 | 250 | 43 |
The journal investigates areas of study like Neuroscience, Central nervous system, Disease, Receptor and Neuroprotection. In particular, the Neuroscience works presented emphasize discussions on Nervous system. It dives deep in exploring the relationship between the study of Synaptic plasticity and Long-term potentiation.
The most cited papers generally zeroe in on subjects such as Neuroscience, Central nervous system, Receptor, Neurotransmission and Synaptic plasticity. The journal publications explore research in Glutamate receptor and overlapping concepts in NMDA receptor to expand the discourse in Neuroscience. The studies tackled in the most cited articles, which mainly focus on Synaptic plasticity, apply to Long-term potentiation as well.
The journal facilitates discussions on Neuroscience, Cell biology, Disease, Synaptic plasticity and Hippocampus. It facilitated presentations on Neuroscience research, particularly Cognition, Central nervous system, Sensory system, Hippocampal formation and Neuropathic pain. The study on Cognition presented in Progress in Neurobiology intersects with subjects under the field of Cortex (anatomy).
It focuses on Neuropathic pain as well as the interrelated topic of Chronic pain. Studies on Cell biology discussed in the journal link to the field of Neurodegeneration. The journal is mostly focused on Disease, specifically Dementia.
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in Progress in Neurobiology (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in Progress in Neurobiology (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 0.79% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 13.49% were posted by at least one author from the top 10 institutions publishing in the journal. Another 5.56% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 19.05% of all publications and 61.90% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
The articles and research conducted and published in Progress in Neurobiology do not merely exist in a vacuum. They have real world implications and applications that impact several professions and lives around the world, including that of Speech-Language Pathologists (SLPs). For instance, understanding neurological diseases and the function of the central nervous system can form a crucial part of an SLP's career.
To become an SLP, a license and registration are important and often mandatory in several states, including South Carolina. The licensure process typically involves thorough education, examination, and fulfillment of the state's qualifications, such as the south carolina slp license requirements.
Once licensed, these professionals can use the most recent research developments published in Progress in Neurobiology to enhance their practice. Research papers on neurodegeneration, for example, may provide insights into innovative methods for assisting patients with dementia. The latest findings in the field of neuropathic pain may offer SLPs alternative strategies to help their clients who are suffering from this condition.
Therefore, keeping up with the latest research from Progress in Neurobiology presents a strategic advantage both for the advancement of those in the field, and for the benefit of the patients they serve every day.
Laura Mahoney-Sánchez;Hind Bouchaoui;Scott Ayton;David Devos
(2021)Suresh L. Mehta;Robert J. Dempsey;Raghu Vemuganti
(2020)Helen C. Barron;Ryszard Auksztulewicz;Karl Friston
(2020)Laurentius Huber;Emily S Finn;Yuhui Chai;Rainer Goebel
(2020)James M. Shine
(2021)Zahra Jafari;Bryan E. Kolb;Majid H. Mohajerani
(2020)Nathan J. Kolla;Marco Bortolato
(2020)Christopher Summerfield;Fabrice Luyckx;Hannah Sheahan
(2020)Shuai Zhang;Brittany Bolduc Lachance;Mark P. Mattson;Xiaofeng Jia
(2021)